AltMountain

RPI US Partners 2019, LP

New York, NY · CIK 1800102 · Sponsor: Pharma Management (Cayman) Ltd.
Status: no Form D since Feb 2020. Funds file a Form D when they begin selling and amend it each year while the offering continues, so this fund has most likely stopped raising money. It may still be investing, or it may have closed or been dissolved. The details below are from its latest filing, kept here as a record.

RPI US Partners 2019, LP is a private investment fund based in New York, New York. Its most recent Form D, filed Feb 10, 2020, reports no sales yet. The filing does not set a minimum investment. It relies on the Section 3(c)(7) exclusion, so investors generally must be qualified purchasers. The offering uses Rule 506(b), which does not permit general solicitation. Related persons named in the filing include Rpi GP 2019, LP; Pablo Legorreta.

Total raised
$0Cumulative sales reported on Form D
Investors
0
First sale
—
Minimum investment
None set
Who can invest
Qualified purchasersSection 3(c)(7): generally $5M+ in investments
Offering exemption
Rule 506(b)No general advertising
Key people and entities
Rpi GP 2019, LP; Pablo Legorreta
Latest Form D
Feb 10, 2020

From SEC filings, not verified. This page republishes the fund's Form D as filed. It is not an offer, solicitation or recommendation, and AltMountain has not reviewed the fund. “Raised” is cumulative sales, not current assets or performance. Returns are not part of SEC filings. Private funds are speculative, illiquid and generally limited to accredited investors or qualified purchasers. Full disclosures · Request a correction⁠​​‌‌‌‌‌‌‌‌​​​​​​​​​‌⁠

Raise history

FiledFilingTotal raisedInvestorsSource
Feb 10, 2020Form D$00SEC.gov ↗
Feb 10, 2020Form D$00SEC.gov ↗

2 Form D filings in the SEC's electronic records (2008 onward), the earliest on Feb 10, 2020. Each filing reports the cumulative amount sold and the number of investors to that date, as the fund filed it. Not verified, and not the fund's current assets. Source: U.S. Securities and Exchange Commission, Form D data sets.

Questions about RPI US Partners 2019, LP

What is the minimum investment for RPI US Partners 2019, LP?

RPI US Partners 2019, LP's latest Form D, filed Feb 10, 2020, does not set a minimum investment. Managers can still require one in the offering documents.

Who can invest in RPI US Partners 2019, LP?

RPI US Partners 2019, LP is generally open only to qualified purchasers (generally individuals with at least $5 million in investments), because it relies on Section 3(c)(7). It uses Rule 506(b), which does not allow general advertising.

How much has RPI US Partners 2019, LP raised?

RPI US Partners 2019, LP's latest Form D, filed Feb 10, 2020, reports no sales yet.

Where is RPI US Partners 2019, LP based?

RPI US Partners 2019, LP is based in New York, New York.

Size compared with every private investment fund

This fund hasn't reported any sales yet.

Other programs from Pharma Management (Cayman) Ltd.

All 5 funds from this sponsor

More private investment funds in New York

Recently filed private investment funds in New York

All private investment funds in New York